{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:25:22Z","timestamp":1791019522528,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008391","name":"UBS Optimus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ophtha.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T10:51:05Z","timestamp":1591527065000},"page":"1603-1611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine"],"prefix":"10.1016","volume":"127","author":[{"given":"Fen Fen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-6882","authenticated-orcid":false,"given":"Ka Wai","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin L.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9827","key":"10.1016\/j.ophtha.2020.06.004_bib1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/S0140-6736(12)60272-4","article-title":"Myopia","volume":"379","author":"Morgan","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ophtha.2020.06.004_bib2","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ophtha.2016.01.006","article-title":"Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050","volume":"123","author":"Holden","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2020.06.004_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/aos.14350","article-title":"High prevalence of myopia in children and their parents in Hong Kong Chinese population: the Hong Kong Children Eye Study","author":"Yam","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.004_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0002-9394(14)76891-6","article-title":"Prevalence of lattice degeneration and its relation to axial length in severe myopia","volume":"111","author":"Celorio","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2020.06.004_bib5","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0161-6420(99)90416-5","article-title":"The relationship between glaucoma and myopia: the Blue Mountains Eye Study","volume":"106","author":"Mitchell","year":"1999","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2020.06.004_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2020.06.004_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/APO.0000000000000256","article-title":"Low-concentration atropine eye drops for myopia progression","volume":"8","author":"Li","year":"2019","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"10.1016\/j.ophtha.2020.06.004_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamaophthalmol.2017.6638","article-title":"Low-dose atropine for myopia control: considering all the data","volume":"136","author":"Bullimore","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2020.06.004_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2020.06.004_bib10","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","article-title":"Two-year clinical trial of the Low-Concentration Atropine for Myopia Progression (LAMP) study: phase 2 report","volume":"127","author":"Yam","year":"2020","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2020.06.004_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/jamaophthalmol.2017.6641","article-title":"Low-dose atropine for myopia control [reply]","volume":"136","author":"Gong","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2020.06.004_bib12","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1167\/iovs.18-24490","article-title":"Effects of monocular atropinization on refractive error and eye growth in infant new world monkeys","volume":"60","author":"Whatham","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2020.06.004_bib13","first-page":"25","author":"Rabbetts","year":"2007"},{"issue":"9","key":"10.1016\/j.ophtha.2020.06.004_bib14","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1167\/iovs.14-14716","article-title":"Analysis of changes in refraction and biometry of atropine- and placebo-treated eyes","volume":"56","author":"Kumaran","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.004_bib15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2020.06.004_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ophtha.2020.06.004_bib17","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1167\/iovs.15-18047","article-title":"Distribution of the crystalline lens power in\u00a0vivo as a function of age","volume":"56","author":"Jongenelen","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ophtha.2020.06.004_bib18","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1167\/iovs.04-1040","article-title":"Axial growth and changes in lenticular and corneal power during emmetropization in infants","volume":"46","author":"Mutti","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642020305200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:08:56Z","timestamp":1758982136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642020305200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":18,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0161642020305200"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.004","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Effects on Ocular Biometrics by 0.05%, 0.025%, and 0.01% Atropine","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}